Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Tongue Neoplasms 1Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Thyroid Cancer, Papillary 1Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Rectal Neoplasms 1Neoplasm Metastasis 1Head and Neck Neoplasms 1Gliosarcoma 1Glioblastoma 1Colorectal Neoplasms 1Colonic Neoplasms 1Central Nervous System Neoplasms 1Carcinoma, Medullary 1Adenocarcinoma, Follicular 1

Interventions

Radiotherapy 15Temozolomide 14Carmustine 6Lomustine 3Chemotherapy, Adjuvant 3Bevacizumab 3imetelstat 2Radiosurgery 2Radiation 2Immunohistochemistry 2Everolimus 2DNA Methylation 2vistusertib 1veliparib 1vatalanib 1temsirolimus 1sagopilone 1rubitecan 1palbociclib 1mercaptoundecahydrododecaborate 1marizomib 1lonafarnib 1fluciclovine F-18 1carmustine, poliferprosan 20 drug combination 1beta-D-glucosylisophosphoramide mustard 1azurin (50-77) 1Tamoxifen 1Re-Irradiation 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Glioblastoma × mercaptoundecahydrododecaborate × Clear all
NCT00004015 2012-07-18

Boron Neutron Capture Therapy Following Surgery in Treating Patients With Glioblastoma Multiforme Removed During Surgery

European Organisation for Research and Treatment of Cancer - EORTC

Phase 1 Completed
36 enrolled
CNSSarcoma

Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡